Laboratorio Reig Jofre Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	6.32	11.82	10.5	8.76	0.01
Depreciation & Amortization	24.79	23.36	23.15	21.06	0.02
Other Adjustments	-14.6	1.07	-0.3	-8.62	-0
Change in Receivables	-6.94	-1.23	-4.73	-	-0
Changes in Inventories	2.53	-2.07	-13.91	-	-0.01
Changes in Accounts Payable	-9.91	-0.25	6.85	-	0
Changes in Other Operating Activities	-0.67	-1.35	-2.43	-1.78	-0
Operating Cash Flow	1.51	31.34	19.12	16.15	0.01
Operating Cash Flow Growth	-95.17%	63.95%	18.38%	111281.66%	-21.94%
Capital Expenditures	-15.29	-20.26	-12.46	-11.4	-0.02
Sale of Property, Plant & Equipment	-	-	-	0.16	0
Purchases of Intangible Assets	-3.01	-0.52	-0.31	-	-0
Purchases of Investments	-0.68	-4.99	-0.34	-2.18	-0
Proceeds from Sale of Investments	0.12	0.39	0.23	0.71	0
Cash Acquisitions	1.05	-6.59	-	-	-0.02
Investing Cash Flow	-17.82	-31.97	-12.88	-12.72	-34.7
Long-Term Debt Issued	32.49	32.88	10.22	15.31	0.03
Long-Term Debt Repaid	-23.9	-28.43	-17.98	-17.33	-0.02
Net Long-Term Debt Issued (Repaid)	8.59	4.45	-7.77	-2.02	0.01
Repurchase of Common Stock	0.08	-0	-0.02	-0.36	-0
Net Common Stock Issued (Repurchased)	0.08	-0	-0.02	-0.36	-0
Common Dividends Paid	-0.03	-0.03	-0.04	-0.05	-0
Other Financing Activities	7.68	1.17	0.67	0.78	0
Financing Cash Flow	16.31	5.59	-7.16	-2.04	0.01
Net Cash Flow	0.01	4.97	-0.93	1.39	-0.01
Free Cash Flow	-13.78	11.08	6.65	4.75	-0
Free Cash Flow Growth	-	66.51%	40.10%	-	-
FCF Margin	-4.16%	3.27%	2.10%	1.75%	-0.00%
Free Cash Flow Per Share	-0.17	0.14	0.08	0.06	-0.00
Levered Free Cash Flow	15.06	14.25	2.83	13.98	5.1
Unlevered Free Cash Flow	4.8	10.58	10.6	16.68	7.76